Home/Paradromics/Vikash Gilja, PhD

VG

Vikash Gilja, PhD

Chief Scientific Officer

Therapeutic Areas

Neurological Disorders Psychiatric Disorders

Paradromics Pipeline

Drug	Indication	Phase
Connexus BCI	Communication restoration in severe paralysis (ALS, stroke, spinal cord injury)	Early Feasibility Study

Leadership Team at Paradromics

Matt Angle, PhD

Founder and CEO

Chief Operating Officer

Stephen Ryu, MD

Chief Medical Officer

Kurtis Nishimura, PhD

Chief Technology Officer

Chief Strategy Officer

View full Paradromics profile